Skip to main content
. 2014 Jul 2;14:116. doi: 10.1186/1471-230X-14-116

Figure 1.

Figure 1

Patients enrolled in this study. Of 242 patients with a clinical diagnosis of PPI-refractory NERD, 95 were elderly patients (≥65 years) with ARD. ARD, acid-related dysmotility symptom; RKT group: rikkunshito (7.5 g/day 3 times) + rabeprazole (10 mg/day), PL group: placebo (7.5 g/day 3 times) + rabeprazole (10 mg/day).